Wolf AS, Ravussin A, König M, Øverås MH, Solum G, Kjønstad IF, Chopra A, Holmøy T, Harbo HF, Syversen SW, Jørgensen KK, Høgestøl EA, Vaage JT, Celius EG, Lund-Johansen F, Munthe LA, Nygaard GO, Mjaaland S(2023) T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis JCI Insight(in press) DOI 10.1172/jci.insight.165111, PubMed 37159281
Martí-Juan G, Sastre-Garriga J, Martinez-Heras E, Vidal-Jordana A, Llufriu S, Groppa S, Gonzalez-Escamilla G, Rocca MA, Filippi M, Høgestøl EA, Harbo HF, Foster MA, Toosy AT, Schoonheim MM, Tewarie P, Pontillo G, Petracca M, Rovira À, Deco G, Pareto D(2023) Using The Virtual Brain to study the relationship between structural and functional connectivity in patients with multiple sclerosis: a multicenter study Cereb Cortex(in press) DOI 10.1093/cercor/bhad041, PubMed 36813475
Andreassen S, Lindland EMS, Beyer MK, Solheim AM, Ljøstad U, Mygland Å, Lorentzen ÅR, Reiso H, Bjuland KJ, Pripp AH, Harbo HF, Løhaugen GCC, Eikeland R(2022) Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis J Neurol, 270(3), 1430-1438 DOI 10.1007/s00415-022-11463-7, PubMed 36380166
